Funding for this research was provided by:
Muscular Dystrophy Association (575466)
Muscular Dystrophy Canada (681255)
Gouvernement du Canada | Canadian Institutes of Health Research (PJT-156379)
Article History
Received: 24 March 2022
Revised: 4 May 2022
Accepted: 12 May 2022
First Online: 26 May 2022
Competing interests
: RK and the Ottawa Hospital Research Institute have a licensing agreement with Biogen for the <i>Smn</i><sup><i>2B/</i>−</sup> mouse model. This COI is outside the scope of this study. All other authors declare no competing interests.